SPHK1靶向NF-κB信号通路调控胃癌细胞的迁移与侵袭

doi:10.12122/j.issn.1673-4254.2024.11.13

南方医科大学学报 ›› 2024, Vol. 44 ›› Issue (11): 2163-2171.doi: 10.12122/j.issn.1673-4254.2024.11.13

SPHK1靶向NF-κB信号通路调控胃癌细胞的迁移与侵袭

凌潜龙¹^,²(), 纪凯¹^,³, 陈金业¹, 管佳佳¹, 王睿朋¹, 满文江¹^,³, 朱冰¹()

^1.蚌埠医科大学第一附属医院胃肠外科，安徽蚌埠 233000
^2.安徽省第二人民医院外科，安徽合肥 230000
^3.海军军医大学第一附属医院//上海长海医院肛肠外科，上海 200082

收稿日期:2024-04-16 出版日期:2024-11-20 发布日期:2024-11-29
通讯作者: 朱冰 E-mail:203551716@qq.com;bbmczhubing@163.com
作者简介:凌潜龙，硕士，E-mail: 203551716@qq.com
基金资助:
安徽省高校科学研究重大项目(KJ2021ZD0090);蚌埠医学院研究生科研创新项目(Byycx22090);安徽省2023年度新时代育人质量工程（研究生教育）项目(2023xscx125)

Sphingosine kinase-1 regulates migration and invasion of gastric cancer cells via targeting the nuclear factor-κB signaling pathway

Qianlong LING¹^,²(), Kai JI¹^,³, Jinye CHEN¹, Jiajia GUAN¹, Ruipeng WANG¹, Wenjiang MAN¹^,³, Bing ZHU¹()

^1.Department of Gastrointestinal Surgery, First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China
^2.Department of Surgery, Second Anhui Provincial People's Hospital, Hefei 230000, China
^3.Department of Colorectal Surgery, Shanghai Changhai Hospital/ First Affiliated Hospital of Naval Medical University, Shanghai 200082, China

Received:2024-04-16 Online:2024-11-20 Published:2024-11-29
Contact: Bing ZHU E-mail:203551716@qq.com;bbmczhubing@163.com

摘要/Abstract

摘要：

目的探讨鞘氨醇激酶-1（SPHK1）在胃癌（GC）组织中的表达及其靶向核因子-κB（NF-κB）调控GC细胞迁移和侵袭能力的分子机制。方法基于TIMER2.0、GEPIA与HPA数据库分析SPHK1在GC组织中的表达。使用Kaplan-Meier Plotter数据库预测SPHK1与GC患者预后的关联。利用IHC检测GC及癌旁组织中SPHK1和MKI67的表达并分析两者相关性。运用Western blotting与qRT-PCR检测GC各细胞系中SPHK1蛋白及mRNA水平。基因富集通路数据库检索SPHK1对GC进展的生物学功能。使用慢病毒敲低HGC-27/过表达MGC-803细胞中SPHK1的表达；采用细胞划痕实验探究SPHK1对GC细胞迁移能力的影响；Transwell实验探究SPHK1对GC细胞迁移和侵袭能力的作用；通过Western blotting检测各蛋白表达情况。体内成瘤实验中，将裸鼠随机分为shNC组、shSPHK1组、oeNC组与oeSPHK1组，利用稳转株验证SPHK1的促癌作用。结果生物信息学表明SPHK1在GC组织中显著高表达（P<0.001）；同时高表达的SPHK1预示着较差的总生存期（P<0.001）和进展后总生存期（P<0.001）以及更差的无复发生存期（P<0.001）。IHC结果表明GC组织中SPHK1与MKI67表达明显上调（P<0.001）且呈正相关（P<0.001）。基因富集通路数据库提示，SPHK1参与GC中的细胞黏附、迁移及血管生成等，且NF-κB参与GC进展（P<0.05）。细胞实验数据显示，抑制SPHK1减弱GC细胞的迁移和侵袭能力，而过表达SPHK1会产生相反的结果（P<0.01）；SPHK1正向调节磷酸化P65 （p-P65）、血管内皮生长因子（VEGFA）和白细胞介素（IL-17）蛋白表达（P<0.05）；利用PDTC阻断NF-κB信号通路可削弱SPHK1促进的GC细胞迁移与侵袭能力以及各蛋白表达水平（P<0.01）；动物实验表明，与NC组相比，shSPHK1组肿瘤大小和质量明显减小，而oeSPHK1组显著增加（P<0.001）。结论 SPHK1可靶向NF-κB信号通路表达进而调控GC细胞的迁移与侵袭，提示SPHK1可能是GC进展的潜在诊断分子标志物。

关键词: 胃癌, 鞘氨醇激酶-1, NF-κB, 迁移, 侵袭

Abstract:

Objective To investigate the role of sphingosine kinase-1 (SPHK1) in regulating migration and invasion of gastric cancer (GC) cells. Methods TIMER2.0, GEPIA and HPA databases were used to investigate SPHK1 expression in GC, and its association with prognosis of the patients was analyzed using Kaplan-Meier Plotter database. In 40 clinical GC and adjacent tissue samples, SPHK1 and MKI67 expressions were detected with immunohistochemistry, Western blotting, and RT-qPCR. Gene enrichment pathway analysis was conducted to explore the biological functions of SPHK1. In HGC-27 and MGC-803 cells, the effects of lentivirus-mediated SPHK1 knockdown or overexpression on cell migration and invasion and expressions of key proteins in the nuclear factor-κB (NF-κB) signaling were evaluated using cell scratch test, Transwell assays and Western blotting. The changes in tumorigenic capacity of the transfected GC cells were evaluated in nude mice. Results SPHK1 was highly expressed in GC tissues in negative correlation with overall survival, overall survival after progression, and relapse-free survival of the patients (all P<0.001). In clinical GC samples, SPHK1 and MKI67 expressions showed a positive correlation (P=0.00049) and were both significantly up-regulated (P<0.001). Gene enrichment pathway analysis suggested the involvement of SPHK1 in cell adhesion, migration, angiogenesis and the NF-κB pathway (P<0.05). In the cell experiment, SPHK1 knockdown significantly decreased while SPHK1 overexpression enhanced migration and invasion abilities of the GC cells. SPHK1 positively regulated the expressions of phosphorylated P65 (P-P65), VEGFA and IL-17, and blocking the NF-κB pathway by PDTC significantly lowered migration and invasion ability of the cells. In nude mice, the GC cells with SPHK1 knockdown resulted in significantly reduced tumor size and mass, while the SPHK1-overexpressing cells showed enhanced tumorigenicity. Conclusion SPHK1 regulates migration and invasion of GC cells via the NF-κB signaling pathway and may serve as a potential diagnostic marker for GC progression.

Key words: gastric cancer, sphingosine kinase-1, NF-κB, migration, invasion

凌潜龙, 纪凯, 陈金业, 管佳佳, 王睿朋, 满文江, 朱冰. SPHK1靶向NF-κB信号通路调控胃癌细胞的迁移与侵袭[J]. 南方医科大学学报, 2024, 44(11): 2163-2171.

Qianlong LING, Kai JI, Jinye CHEN, Jiajia GUAN, Ruipeng WANG, Wenjiang MAN, Bing ZHU. Sphingosine kinase-1 regulates migration and invasion of gastric cancer cells via targeting the nuclear factor-κB signaling pathway[J]. Journal of Southern Medical University, 2024, 44(11): 2163-2171.

图/表 8

表1 SPHK1在GC中的表达与临床病理特征的关系

Tab.1 Clinicopathological characteristics of GC patients (n=40)

Characteristic	Clinicopathological characteristics
Characteristic	n	Percentage (%)
Gender
Male	28	70
Female	12	30
Age (year)
≥60	24	60
<60	16	40
Tumor size (cm)
≥5.0	22	55
<5.0	18	45
Clinical stage
I+II	14	35
III+IV	26	65
N stage
N0	10	25
N1+N2+N3	30	75

表2 RNA干扰和过表达序列

Tab.2 Sequences for RNA interference or gene overexpression

Item	Sequences (5'-3')
shNC	GAGTCTATGACATTGCCTCA
shSPHK1#1	CTTCGTGTCAGATGTTGGATAT
shSPHK1#2	GCTTTGCCCTCACCCTTACAT
shSPHK1#3	GCTTTGCCCTCACCCTTACAT
oeNC	CGCATCTAGCCTGTCAGTCC
oeSPHK1#1	CTCGTGTCAGATATTGGTTAT
oeSPHK1#2	ATTGTGTGAGACATCCGTAAG
oeSPHK1#3	TTGAGTCCTGCTTCTTCATTG

图1 SPHK1在GC组织中的表达

Fig.1 Expression of SPHK1 in GC tissues. A: Expression of SPHK1 in pan-cancer based on data retrieved from TIMER2.0 database. B: Expression of SPHK1 and MKI67 in GC tissues based on data retrieved from GEPIA database. C: GEPIA database analysis of the correlation between SPHK1 and MKI67. D, E: Immunohistochemical staining for SPHK1 and MKI67 in GC tissues from HPA database. *P<0.05, **P<0.01, ***P<0.001 vs Tumor group.

图2 SPHK1表达与GC患者预后的关联

Fig.2 Association of SPHK1 expression with overall survival (OS; A), post-progression survival (PPS; B) and recurrence-free survival (RFS; C) of GC patients predicted using Kaplan-Meier Plotter database.

图3 GC组织中SPHK1表达的上调

Fig.3 SPHK1 expression is upregulated in GC tissue. A: Immunohistochemical staining for detecting SPHK1 and MKI67 in clinical tissue samples (Original magnification:×200). B: Immunohistochemical score of SPHK1 and MKI67. ***P<0.001. C: Correlation between SPHK1 and MKI67 expressions. D: Western blotting for detecting the expression of SPHK1 protein. E: qRT-PCR for detecting the level of SPHK1 mRNA. *P<0.05, **P<0.01, ***P<0.001 vs GES-1 group.

图4 SPHK1对GC细胞迁移与侵袭的影响

Fig.4 Effect of SPHK1 knockdown or overexpression on GC cell migration and invasion. A: Western blotting for assessing efficiency of lentivirus-mediated SPHK1 knockdown and overexpression. B: Western blotting for detecting MKI67 protein levels. C, E: Cell scratch assay for assessing migration ability of the cells (×40). D, F: Transwell assays for assessing invasion ability of the cells (×200). G: Size of the subcutaneous tumors in nude mice. F: Weight of the subcutaneous tumors. *P<0.05, **P<0.01, ***P<0.001 vs NC group.

图5 SPHK1靶向NF-κB信号通路

Fig.5 SPHK1 targets the NF-κB signaling pathway. A: Results of GO enrichment analysis. B: Results of KEGG pathway enrichment analysis. C, E: Expression levels of NF-κB signaling pathway proteins after SPHK1 knockdown. D, F: Expression levels of the proteins after SPHK1 overexpression. *P<0.05, **P<0.01, ***P<0.001 vs NC group.

图6 阻断NF-κB信号通路, SPHK1对GC细胞的迁移与侵袭能力的影响

Fig.6 Effect of blocking the NF-κB signaling pathway on migration and invasion ability of GC cells with SPHK1 knockdown or overexpression. A, B: Transwell assay for assessing migration and invasion of GC cells treated with 100 nmol/L PDTC (a NF-κB pathway inhibitor) or DMSO for 24 h (×200). C-F: Western blotting for detecting the levels of P65, p-P65, VEGFA and IL-17 proteins.*P<0.05, **P<0.01, ***P<0.001.

参考文献 39

1	冯金华, 刘亚江, 颜慧玲, 等. 四君子汤对胃癌肿瘤干细胞标志物活性及TFAP4蛋白的作用机制[J].中国老年学杂志,2024,44(7):1739-44.
2	Wang X, Wu WKK, Gao J, et al. Autophagy inhibition enhances PD-L1 expression in gastric cancer[J]. J Exp Clin Cancer Res, 2019, 38(1): 140.
3	Yang WJ, Zhao HP, Yu Y, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer[J]. World J Gastroenterol, 2023, 29(16): 2452-68.
4	Yeong J, Teo CB, Tay RYK, et al. Reply to: letter to editor on the article "Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy"[J]. Gastric Cancer, 2022, 25(6): 1133-5.
5	Tang L, Guo CM, Li X, et al. TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway[J]. Sci Rep, 2023, 13(1): 5846.
6	Qin ZJ, Tong H, Li TH, et al. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis[J]. Int J Mol Med, 2021, 48(5): 204.
7	Bernacchioni C, Squecco R, Gamberi T, et al. S1P signalling axis is necessary for adiponectin-directed regulation of electrophysio-logical properties and oxidative metabolism in C2C12 myotubes[J]. Cells, 2022, 11(4): 713.
8	张文路, 徐春燕. SphK1/S1P在肿瘤恶性生物学行为中的研究进展[J]. 实用医学杂志, 2023, 39(19): 2551-5, 2560. DOI: 10.3969/j.issn.1006-5725.2023.19.024
9	Long JT, Yao ZJ, Sui Y, et al. SphK1 promotes cancer progression through activating JAK/STAT pathway and up-regulating S1PR1 expression in colon cancer cells[J]. Anticancer Agents Med Chem, 2022, 22(2): 254-60.
10	Wu JN, Lin L, Luo SB, et al. SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer[J]. Cancer Med, 2021, 10(17): 6010-21.
11	Liu SQ, Xu CY, Wu WH, et al. Sphingosine kinase1 promotes the metastasis of colorectal cancer by inducing the epithelial-mesenchymal transition mediated by the FAK/AKT/MMPs axis[J]. Int J Oncol, 2019, 54(1): 41-52.
12	Yu MS, Zhang KN, Wang S, et al. Increased SPHK1 and HAS2 expressions correlate to poor prognosis in pancreatic cancer[J]. Biomed Res Int, 2021, 2021: 8861766.
13	Ma Y, Xing X, Kong R, et al. SphK1 promotes development of non-small cell lung cancer through activation of STAT3[J]. Int J Mol Med, 2021, 47(1): 374-86.
14	卢芳, 蒋鑫, 徐晓敏, 等.分子对接与体内验证联合探讨穿山龙复方对痛风模型大鼠TLR4/MyD88/NF-kB信号通路的影响[J].中药药理与临床, 2023, 39(08): 25-31.
15	Wang MD, Li HT, Peng LX, et al. TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling[J]. Cancer Gene Ther, 2024, 31(3): 454-63.
16	Yang WH, Liu L, Li CX, et al. TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway[J]. Cell Death Dis, 2018, 9(9): 908.
17	张浩, 张震, 王秋生, 等. FJX1在胃癌组织中高表达并与不良预后相关[J]. 南方医科大学学报, 2023, 43(6): 975-84.
18	Sukocheva OA, Furuya H, Ng ML, et al. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: a novel therapeutic target[J]. Pharmacol Ther, 2020, 207: 107464.
19	刘加蒙, 李明. S1PR1在胃癌组织中的表达及其临床意义[J]. 现代肿瘤医学, 2024, 32(1): 93-5.
20	Xiong HP, Wang JC, Guan HY, et al. SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stim-ulating Akt/FoxO3a signaling[J]. Oncol Rep, 2014, 32(4): 1369-73.
21	Jia ZW, Tang XF, Zhang XC, et al. MiR-153-3p attenuates the development of gastric cancer by suppressing SphK2[J]. Biochem Genet, 2022, 60(5): 1748-61.
22	Huo FC, Zhu ZM, Zhu WT, et al. METTL3-mediated m⁶A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2[J]. Oncogene, 2021, 40(16): 2968-81.
23	Uxa S, Castillo-Binder P, Kohler R, et al. Ki-67 gene expression[J]. Cell Death Differ, 2021, 28(12): 3357-70.
24	Leibold J, Tsanov KM, Amor C, et al. Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease[J]. Nat Cancer, 2024, 5(2): 315-29.
25	Ruan Q, Wang CJ, Wu YT, et al. Exosome microRNA-22 inhibiting proliferation, migration and invasion through regulating Twist1/CADM1 axis in osteosarcoma[J]. Sci Rep, 2024, 14(1): 761.
26	Bhadwal P, Randhawa V, Vaiphei K, et al. Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance[J]. Sci Rep, 2022, 12(1): 18239.
27	Jin L, Zhu J, Yao LY, et al. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth[J]. Cell Death Dis, 2023, 14(8): 537.
28	Chen D, Wu JN, Qiu XZ, et al. SPHK1 potentiates colorectal cancer progression and metastasis via regulating autophagy mediated by TRAF6-induced ULK1 ubiquitination[J]. Cancer Gene Ther, 2024, 31(3): 410-9.
29	Long XL, Hu YK, Duan SY, et al. MRGBP promotes colorectal cancer metastasis via DKK1/Wnt/β-catenin and NF-kB/p65 pathways mediated EMT[J]. Exp Cell Res, 2022, 421(1): 113375.
30	Mirzaei S, Saghari S, Bassiri F, et al. NF-κB as a regulator of cancer metastasis and therapy response: a focus on epithelial-mesenchymal transition[J]. J Cell Physiol, 2022, 237(7): 2770-95.
31	冯晓创. POTEE通过调控SPHK1转录激活p65磷酸化促进结直肠癌进展的机制研究[D]. 广州: 南方医科大学, 2020.
32	Hou CX, Mao GY, Sun QW, et al. Metabolomic analysis reveals that SPHK1 promotes oral squamous cell carcinoma progression through NF-κB activation[J]. Ann Surg Oncol, 2022, 29(12): 7386-99.
33	Zhang JX, Chen ZH, Chen DL, et al. Retraction Note: LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis[J]. Oncogene, 2023, 42(14): 1158.
34	Li YF, Qiao YQ, Wang HH, et al. Intraperitoneal injection of PDTC on the NF-kB signaling pathway and osteogenesis indexes of young adult rats with anterior palatal suture expansion model[J]. PLoS One, 2021, 16(7): e0243108.
35	Mei L, Zheng YM, Song TY, et al. Rieske iron-sulfur protein induces FKBP12.6/RyR2 complex remodeling and subsequent pulmonary hypertension through NF‑κB/cyclin D1 pathway[J]. Nat Commun, 2020, 11(1): 3527.
36	Yang KX, Li JT, Zhu JH, et al. HOOK3 suppresses proliferation and metastasis in gastric cancer via the SP1/VEGFA axis[J]. Cell Death Discov, 2024, 10(1): 33.
37	Zeng K, Xie WW, Wang CY, et al. USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma[J]. Cell Death Dis, 2023, 14(3): 194.
38	李燕, 王琦, 郑路, 等.白细胞介素-17基因多态性与山西东南地区汉族人群2型糖尿病的相关性[J].实用医学杂志, 2024, 40(05): 695-701.
39	Korbecki J, Simińska D, Gąssowska-Dobrowolska M, et al. Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF‑κB activation: a review of the molecular mechanisms[J]. Int J Mol Sci, 2021, 22(19): 10701.

[1]	陈鑫源, 吴成挺, 李瑞迪, 潘雪芹, 张耀丹, 陶俊宇, 林才志. 双术汤通过P53/SLC7A11/GPX4通路诱导胃癌细胞铁死亡[J]. 南方医科大学学报, 2025, 45(7): 1363-1371.
[2]	范正媛, 沈子涵, 李亚, 沈婷婷, 李高峰, 李素云. 补肺益肾方对香烟烟雾提取物诱导的人支气管上皮细胞损伤的保护作用及其机制[J]. 南方医科大学学报, 2025, 45(7): 1372-1379.
[3]	龚秀莹, 侯顺福, 赵苗苗, 王晓娜, 张致涵, 刘清华, 尹崇高, 李洪利. LncRNA SNHG15通过miR-30b-3p调控COX6B1轴促进肺腺癌细胞增殖、迁移和侵袭的分子机制[J]. 南方医科大学学报, 2025, 45(7): 1498-1505.
[4]	吴璇, 方家敏, 韩玮玮, 陈琳, 孙菁, 金齐力. 高表达PRELID1促进胃癌细胞上皮间质转化并与不良预后相关[J]. 南方医科大学学报, 2025, 45(7): 1535-1542.
[5]	夏冰, 彭进, 丁九阳, 王杰, 唐国伟, 刘国杰, 王沄, 万昌武, 乐翠云. ATF3通过NF-κB信号通路调控动脉粥样硬化斑块内的炎症反应[J]. 南方医科大学学报, 2025, 45(6): 1131-1142.
[6]	李嘉豪, 冼瑞婷, 李荣. 下调ACADM介导的脂毒性抑制雌激素受体阳性乳腺癌细胞的侵袭与转移[J]. 南方医科大学学报, 2025, 45(6): 1163-1173.
[7]	侯鑫睿, 张振东, 曹明远, 杜予心, 王小平. 红景天苷靶向miR-1343-3p-OGDHL/PDHB糖代谢轴抑制胃癌细胞的体内外增殖[J]. 南方医科大学学报, 2025, 45(6): 1226-1239.
[8]	梁晓涛, 熊一凡, 刘雪琪, 梁小珊, 朱晓煜, 谢炜. 活血疏风颗粒通过抑制TLR4/NF-κB通路改善慢性偏头痛小鼠的中枢敏化[J]. 南方医科大学学报, 2025, 45(5): 986-994.
[9]	岳雅清, 牟召霞, 王希波, 刘艳. Aurora-A过表达通过激活NF-κBp65/ARPC4信号轴促进宫颈癌细胞的侵袭和转移[J]. 南方医科大学学报, 2025, 45(4): 837-843.
[10]	张毅, 沈昱, 万志强, 陶嵩, 柳亚魁, 王栓虎. CDKN3高表达促进胃癌细胞的迁移和侵袭：基于调控p53/NF-κB信号通路和抑制胃癌细胞凋亡[J]. 南方医科大学学报, 2025, 45(4): 853-861.
[11]	庆顺杰, 沈智勇. 过表达己糖激酶2通过激活JAK/STAT途径促进结直肠癌细胞的增殖、迁移和侵袭并调节肿瘤免疫微环境[J]. 南方医科大学学报, 2025, 45(3): 542-553.
[12]	陶露, 韦卓利, 王月月, 项平. CEACAM6通过调控上皮间质转化抑制鼻咽癌细胞的增殖和迁移[J]. 南方医科大学学报, 2025, 45(3): 566-576.
[13]	黄晴晴, 张文静, 张小凤, 王炼, 宋雪, 耿志军, 左芦根, 王月月, 李静, 胡建国. 高表达MYO1B促进胃癌细胞增殖、迁移和侵袭并与患者的不良预后有关[J]. 南方医科大学学报, 2025, 45(3): 622-631.
[14]	宋雪, 陈悦, 张敏, 张诺, 左芦根, 李静, 耿志军, 张小凤, 王月月, 王炼, 胡建国. GPSM2在胃癌组织中高表达并通过促进肿瘤细胞的增殖影响患者预后[J]. 南方医科大学学报, 2025, 45(2): 229-238.
[15]	曹周芳, 汪元, 王梦娜, 孙玥, 刘菲菲. LINC00837/miR-671-5p/SERPINE2功能轴促进类风湿关节炎成纤维细胞样滑膜细胞的恶性病理学过程[J]. 南方医科大学学报, 2025, 45(2): 371-378.

SPHK1靶向NF-κB信号通路调控胃癌细胞的迁移与侵袭

Sphingosine kinase-1 regulates migration and invasion of gastric cancer cells via targeting the nuclear factor-κB signaling pathway

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 8

参考文献 39

相关文章 15

编辑推荐

Metrics

本文评价